SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a class of novel oral anti-hyperglycemic agents which are increasingly used in clinical practice. SGLT-2 inhibitors improve glycemic control and cardiorenal outcomes, promote weight loss, and reduce blood pressure. Randomized controlled trials h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalay, Zeynepgul, Sahin, Ozgun E, Copur, Sidar, Danacı, Senem, Ortiz, Alberto, Yau, Kevin, Cherney, David Z I, Kanbay, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871839/
https://www.ncbi.nlm.nih.gov/pubmed/36726436
http://dx.doi.org/10.1093/ckj/sfac189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871839/
https://www.ncbi.nlm.nih.gov/pubmed/36726436
http://dx.doi.org/10.1093/ckj/sfac189

Ejemplares similares